Trial Profile
A Randomized Controlled Trial of Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Obstructive airway disorders; Sleep apnoea syndrome
- Focus Therapeutic Use
- Acronyms Nasonex OSA
- 29 Jul 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 28 Aug 2012 New trial record